Hydrogen Science is “Really” the Science of Longer Life and Better Quality of Life — Free Radicals Damage Our Molecules, Mitochondria, DNA, Cell Membranes, Etc. — Aging Us. — Hydrogen atoms stop that damage. They are reductants, or ANTI–OXIDANTS — They Work to Keep Us Younger, Longer. In other words, YOU NEED THEM!	Science   Redox   Research   Lecture   CellFood
Free Radicals Are The Silent, Ever-Present Destroyers Of Molecules, Cells and Life:

• Science has taught us that free radicals are molecules missing one or more electrons. They are either created inside one's body during metabolism or they enter as external toxins that a person has breathed, drunk, eaten or absorbed through the skin.
• Once inside a person's body, free radicals do great and continuing damage unless they are neutralized.
• For the above reason, free radicals need to be neutralized by receiving an electron from an anti-oxidant, which is a special kind of molecule that can give away an electron without, itself becoming a free radical (or, as in the case of Vitamin C and Vitamin E, without becoming an aggressive free-radical). Technically, an anti-oxidant REDuces the OXidant, which is why this process is sometimes called REDOX.
• Hydrogen atoms are the simplest and most effective of all antioxidant molecules, and are readily able to neutralize free radicals.
• Active hydrogen, which is free hydrogen, IE, hydrogen not bonded to another atom,  consists of one proton and one electron, and the electron is easily given to an oxygen radical (one of the most common free radicals) or to other types of free radicals that may be missing an electron. In the former case, the Hydrogen atom combines with an oxygen free radical to make water which further hydrates the body, helping the body in virtually every way.
• In other words, as hydrogen reduces free radicals, it does not, itself, become a free radical
• and it also increases one's hydration, which is a WIN-WIN.
• Because hydrogen is so small, hydrogen can go everywhere in the body, and penetrate all organs and tissues  to neutralize free radicals.

 

 

Aging is progressive cellular damage... and most often that damage is caused by unbalanced REDOX... meaning that there are too many free radicals in the body... or in other words there are more oxidizing actions (stripping electrons from healthy molecules) than reducing actions (adding electrons to molecules that are missing them)!

When discussing human health disorders (in general), Dr. Hidemitsu Hayashi said, “A single key mechanism of disease (and aging) that dominates all others is nothing but REDOX reaction. So that, if we can find a way to control it (the REDOX reaction), we can conquer the disorder. Water rich in atomic as well as molecular hydrogen should be an ultimate solution for it as far as my theory is concerned.”

Again, because Hydrogen is such a small atom, it easily penetrates all tissues and fluids of the body, whether brain tissue, mitochondria, bone or cellular cytoplasm, while other larger antioxidants do not have such a freedom, and are thus limited in their reach and scope of benefit. Thus, supplying hydrogen atoms to the body is just about the highest priority one should have in preserving health.

Scientists Have Been Learning About the Health Benefits of Hydrogen for Nearly a Century

— Scientists has been learning the importance of the hydrogen atom in human health over the past 80 years.

In 1937 - Dr. Györgyi reports that Hydrogen is at the root of energy creation

The first scientist to talk about hydrogen was Dr. Szent-Györgyi who won the Nobel Prize for Vitamin C curing scurvy in 1937.

In his discovery he found that Hydrogen is the only fuel the body recognizes and describes the body's natural process of digesting carbohydrates to provide hydrogen in the making of ATP or energy for the body.

Says Dr. Györgyi, “the fact that our body really only knows one fuel, hydrogen. The foodstuff, carbohydrate, is essentially a packet of hydrogen, a hydrogen supplier, a hydrogen donor, and the main event during its combustion is the splitting off of hydrogen. So the combustion of hydrogen is the real energy-supplying reaction; To the elucidation of reaction (6), which seems so simple, I have devoted all my energy for the last fifteen years.”€� - Albert Szent-Györgyi, PhD

 

The Nobel Prize was awarded to Dr. Peter Mitchell in 1978 for his theory of hydrogen’s essentiality to chemiosmosis (mitochondrial energy).

According to this model of Dr. Peter Mitchell, Hydrogen is essential in the production of ATP in the mitochondria, the source of all energy in the cells, and therefore the body. This works through hydrogen dehydrogenase, a flavoprotein catalyzing the conversion of NAD+ to NADH by molecular hydrogen (H2); H2 + NAD  → H+ + NADH. Molecular hydrogen, H2, is very prevalent in our hydrogen-rich water as shown by research certificate from the Shiga Institute. This is the seminal work in cellular energy production also helps explain the energy on demand available from hydrogen-rich water.

What is the bottom line of this structure and function claim? Clearly, ATP production can be supported by the increased presence of molecular hydrogen, and this explains the consistently positive reports we receive from athletes attesting to dramatic increases in energy reserves.

 

Come forward to today and now thanks  to Dr. Hidemitsu Hayashi, MD cardiac surgeon has found a way to bring  hydrogen to the body that is inexpensive, portable and available to all.

• Born in 1938.
• Graduated from the Kobe University School of Medicine in 1968.
• Studied at the University of Munich (1970-71).
• Specialized in the field of Cardiovascular Medicine.
• In 1985, began researching the medical benefits of water.
• In 1995, simultaneously released in Japan and the U.S., his theory on the effects of hydrogen-rich water in preventing and treating illnesses.
• In September 2001 developed a  hydrogen-generating mineral stick, The Hydrogen Rich Water Stick™, as a  means for anyone to easily and affordably produce hydrogen-rich water.

REFERENCES

1. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407. [PMC free article] [PubMed]
2. Ferrari R, Ceconi C, Curello S, Cargnoni A, Pasini E, Visioli O. The occurrence of oxidative stress during reperfusion in experimental animals and men. Cardiovasc Drugs Ther. 1991;5(Suppl 2):277–87. [PubMed]
3. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med. 2004;10(Suppl):S18–25. [PubMed]
4. Ohta S, Ohsawa I. Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification. J Alzheimers Dis. 2006;9:155–66. [PubMed]
5. Ohta S, Ohsawa I, Kamino K, Ando F, Shimokata H. Mitochondrial ALDH2 deficiency as an oxidative stress. Ann N Y Acad Sci. 2004;1011:36–44. [PubMed]
6. Chang JC, Kou SJ, Lin WT, Liu CS. Regulatory role of mitochondria in oxidative stress and atherosclerosis. World J Cardiol. 2010;2:150–9. [PMC free article] [PubMed]
7. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–47. [PubMed]
8. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol. 2008;101:14D–9D. [PubMed]
9. Hercberg S, Kesse-Guyot E, Druesne-Pecollo N, et al. Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study. Int J Cancer. 2010;127:1875–81. [PubMed]
10. Brambilla D, Mancuso C, Scuderi MR, et al. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile. Nutr J. 2008;7:29. [PMC free article] [PubMed]
11. Hackam DG. Review: antioxidant supplements for primary and secondary prevention do not decrease mortality. ACP J Club. 2007;147:4. [PubMed]
12. Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688–94. [PubMed]
13. Salganik RI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J. Am. Coll. Nutr. 2001;20:464S–72S. [PubMed]
14. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 2001;11:173–86. [PubMed]
15. Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ. Res. 2005;97:967–74. [PubMed]
16. Harma MI, Harma M, Erel O. Measuring plasma oxidative stress biomarkers in sport medicine. Eur J Appl Physiol. 2006;97:505. [PubMed]
17. Tanriverdi H, Evrengul H, Kuru O, et al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J. 2006;70:593–9. [PubMed]
18. Grassi D, Desideri G, Ferri L, Aggio A, Tiberti S, Ferri C. Oxidative stress and endothelial dysfunction: say no to cigarette smoking. Curr Pharm Des. 2010;16:2539–50. [PubMed]
19. Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol. 2005;6:13. [PMC free article] [PubMed]
20. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:335–44. [PMC free article] [PubMed]
21. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787–95. [PubMed]
22. Halliwell B, Gutteridge JM. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett. 1992;307:108–12. [PubMed]
23. Peled-Kamar M, Lotem J, Wirguin I, Weiner L, Hermalin A, Groner Y. Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase. Proc Natl Acad Sci U S A. 1997;94:3883–7. [PMC free article] [PubMed]
24. Chan PH, Epstein CJ, Li Y, et al. Transgenic mice and knockout mutants in the study of oxidative stress in brain injury. J Neurotrauma. 1995;12:815–24. [PubMed]
25. Mitsui A, Hamuro J, Nakamura H, et al. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal. 2002;4:693–6. [PubMed]
26. Stefanova N, Reindl M, Neumann M, et al. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol. 2005;166:869–76. [PMC free article] [PubMed]
27. Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005;308:1909–11. [PubMed]
28. Stockl P, Zankl C, Hutter E, et al. Partial uncoupling of oxidative phosphorylation induces premature senescence in human fibroblasts and yeast mother cells. Free Radic Biol Med. 2007;43:947–58. [PubMed]
29. Jia JJ, Zhang X, Ge CR, Jois M. The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes. Obes Rev. 2009;10:519–26. [PubMed]
30. Jia JJ, Tian YB, Cao ZH, et al. The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes. Mol. Biol. Rep. 2010;37:1513–22. [PubMed]
31. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ. Res. 2010;107:1058–70. [PMC free article] [PubMed]
32. Ohsawa I, Nishimaki K, Murakami Y, Suzuki Y, Ishikawa M, Ohta S. Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity. J Neurosci. 2008;28:6239–49. [PubMed]
33. Endo J, Sano M, Katayama T, Hishiki T, et al. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Circ Res. 2009;105:1118–27. [PubMed]
34. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:1603–16. [PMC free article] [PubMed]
35. Vaziri ND, Rodriguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol. 2006;2:582–93. [PubMed]
36. Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res. 1989;65:607–22. [PubMed]
37. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem. 1988;263:1353–7. [PubMed]
38. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest. 1988;82:476–85. [PMC free article] [PubMed]
39. Vanden Hoek T, Becker LB, Shao ZH, Li CQ, Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res. 2000;86:541–8. [PubMed]
40. Halliwell B, Gutteridge JM. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 1986;246:501–14. [PubMed]
41. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta. 2007;1767:1007–31. [PMC free article] [PubMed]
42. Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, George BS, Kereiakes DJ, Deitchman D, Gustafson N, et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation. 1994;89:1982–91. [PubMed]
43. Richard VJ, Murry CE, Jennings RB, Reimer KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. Circulation. 1988;78:473–80. [PubMed]
44. Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis) Exp Gerontol. 2010;45:410–8. [PubMed]
45. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A. 2009;106:8665–70. [PMC free article] [PubMed]
46. Penna C, Rastaldo R, Mancardi D, et al. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol. 2006;101:180–9. [PubMed]
47. Downey JM, Cohen MV. A really radical observation--a comment on Penna et al. in Basic Res Cardiol (2006) 101:180-189. Basic Res Cardiol. 2006;101:190–1. [PubMed]
48. Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. 2010;44:971–82. [PubMed]
49. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem. 2003;278:3170–5. [PubMed]
50. Kikkawa YS, Nakagawa T, Horie RT, Ito J. Hydrogen protects auditory hair cells from free radicals. Neuroreport. 2009;20:689–94. [PubMed]
51. Taura A, Kikkawa YS, Nakagawa T, Ito J. Hydrogen protects vestibular hair cells from free radicals. Acta Otolaryngol Suppl. 2010;00:95–100. [PubMed]
52. Qian L, Cao F, Cui J, et al. Radioprotective effect of hydrogen in cultured cells and mice. Free Radic Res. 2010;44:275–82. [PubMed]
53. Schoenfeld MP, Ansari RR, Zakrajsek JF, et al. Hydrogen therapy may reduce the risks related to radiation-induced oxidative stress in space flight. Med Hypotheses. 2011;76:117–8. [PubMed]
54. Kawasaki H, Guan J, Tamama K. Hydrogen gas treatment prolongs replicative lifespan of bone marrow multipotential stromal cells in vitro while preserving differentiation and paracrine potentials. Biochem Biophys Res Commun. 2010;397:608–13. [PubMed]
55. 55. Murphy MP, Smith RA. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev. 2000;41:235–50. [PubMed]
56. Murphy MP. Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol. 1997;15:326–30. [PubMed]
57. Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov Med. 2011;11:106–14. [PubMed]
58. Hayashida K, Sano M, Ohsawa I, et al. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 2008;373:30–5. [PubMed]
59. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–57. [PubMed]
60. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008:CD007176. [PubMed]
61. Gray SL, Anderson ML, Crane PK, et al. Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. J Am Geriatr Soc. 2008;56:291–5. [PubMed]
62. Walker C. Antioxidant supplements do not improve mortality and may cause harm. Am Fam Physician. 2008;78:1079–80. [PubMed]
63. Bjelakovic G, Gluud C. Surviving antioxidant supplements. J. Natl. Cancer Inst. 2007;99:742–3. [PubMed]
64. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005;142:37–46. [PubMed]
65. Mandal CC, Ganapathy S, Gorin Y, et al. Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation. Biochem J. 2010;433:393–402. [PubMed]
66. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998;95:11715–20. [PMC free article] [PubMed]
67. 67. Carriere A, Carmona MC, Fernandez Y, et al. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem. 2004;279:40462–9. [PubMed]
68. Winterbourn CC. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology. 2002;181-182:223–7. [PubMed]
69. Murad F. Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci. Rep. 2004;24:452–74. [PubMed]
70. Kajimura M, Fukuda R, Bateman RM, Yamamoto T, Suematsu M. Interactions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal. 2010;13:157–92. [PMC free article] [PubMed]
71. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9:728–43. [PubMed]
72. Kimura H. Hydrogen sulfide: from brain to gut. Antioxid Redox Signal. 2010;12:1111–23. [PubMed]
73. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007;6:917–35. [PubMed]
74. Elrod JW, Calvert JW, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A. 2007;104:15560–5. [PMC free article] [PubMed]
75. Foresti R, Bani-Hani MG, Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med. 2008 [PubMed]
76. Kobayashi A, Ishikawa K, Matsumoto H, Kimura S, Kamiyama Y, Maruyama Y. Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy. Hypertension. 2007;50:1040–8. [PubMed]
77. Bloch KD, Ichinose F, Roberts JD, Jr, Zapol WM. Inhaled NO as a therapeutic agent. Cardiovasc Res. 2007;75:339–48. [PMC free article] [PubMed]
78. Abraini JH, Gardette-Chauffour MC, Martinez E, Rostain JC, Lemaire C. Psychophysiological reactions in humans during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture. J Appl Physiol. 1994;76:1113–8. [PubMed]
79. Lillo RS, Parker EC, Porter WR. Decompression comparison of helium and hydrogen in rats. J Appl Physiol. 1997;82:892–901. [PubMed]
80. Lillo RS, Parker EC. Mixed-gas model for predicting decompression sickness in rats. J Appl Physiol. 2000;89:2107–16. [PubMed]
81. Fontanari P, Badier M, Guillot C, et al. Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa Hydra 10 record human dive. Eur J Appl Physiol. 2000;81:325–8. [PubMed]
82. Peters O, Back T, Lindauer U, et al. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1998;18:196–205. [PubMed]
83. Jaeschke H, Smith CV, Mitchell JR. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J. Clin. Invest. 1988;81:1240–6. [PMC free article] [PubMed]
84. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun. 2007;361:670–4. [PubMed]
85. Buchholz BM, Kaczorowski DJ, Sugimoto R, et al. Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant. 2008;8:2015–24. [PubMed]
86. Kawamura T, Huang CS, Tochigi N, et al. Inhaled hydrogen gas therapy for prevention of lung transplant-induced ischemia/reperfusion injury in rats. Transplantation. 2010;90:1344–51. [PubMed]
87. Nakao A, Kaczorowski DJ, Wang Y, et al. Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant. 2010;29:544–53. [PubMed]
88. Huang CS, Kawamura T, Lee S, et al. Hydrogen inhalation ameliorates ventilator-induced lung injury. Crit Care. 2010;14:R234. [PMC free article] [PubMed]
89. Victor VM, Espulgues JV, Hernandez-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets. 2009;9:376–89. [PubMed]
90. Xie KL, Yu YH, Pei YP, et al. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock. 2010;34:90–7. [PubMed]
91. Xie K, Yu Y, Zhang Z, et al. Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock. 2010;34:495–501. [PubMed]
92. Cai J, Kang Z, Liu WW, et al. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 2008;441:167–72. [PubMed]
93. Chen CH, Manaenko A, Zhan Y, Liu WW, Ostrowki RP, Tang J, Zhang JH. Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. Neuroscience. 2010;169:402–14. [PMC free article] [PubMed]
94. Domoki F, Olah O, Zimmermann A, et al. Hydrogen is neuroprotective and preserves cerebrovascular reactivity in asphyxiated newborn pigs. Pediatr Res. 2010;68:387–92. [PubMed]
95. Ji X, Liu W, Xie K, et al. Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress. Brain Res. 2010;1354:196–205. [PubMed]
96. Huang Y, Xie K, Li J, et al. Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits. Brain Res. 2011;1378:125–36. [PubMed]
97. Taura A, Kikkawa YS, Nakagawa T, Ito J. Hydrogen protects vestibular hair cells from free radicals. Acta Otolaryngol. (Stockh) 2010;130:95–100. [PubMed]
98. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S. Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Neuropsychopharmacology. 2009;34:501–8. [PubMed]
99. Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 2009;64:753–61. [PubMed]
100. Liu J, Wang X, Shigenaga MK, Yeo HC, Mori A, Ames BN. Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats. FASEB J. 1996;10:1532–8. [PubMed]
101. Abrous DN, Koehl M, Le Moal M. Adult neurogenesis: from precursors to network and physiology. Physiol Rev. 2005;85:523–69. [PubMed]
102. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 2008;7:97–109. [PubMed]
103. Fu Y, Ito M, Fujita Y, et al. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett. 2009;453:81–5. [PubMed]
104. Fujita K, Seike T, Yutsudo N, et al. Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. PLoS One. 2009;4:e7247. [PMC free article] [PubMed]
105. Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Curr Med Chem. 2009;16:4654–67. [PubMed]
106. Stocker R, Keaney JF., Jr Role of oxidative modifications in atherosclerosis. Physiol. Rev. 2004;84:1381–478. [PubMed]
107. 107. Upston JM, Kritharides L, Stocker R. The role of vitamin E in atherosclerosis. Prog. Lipid Res. 2003;42:405–22. [PubMed]
108. Hodis HN, Mack WJ, LaBree L, et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS) Circulation. 2002;106:1453–9. [PubMed]
109. Kolovou G, Anagnostopoulou K, Mikhailidis DP, Cokkinos DV. Apolipoprotein E knockout models. Curr Pharm Des. 2008;14:338–51. [PubMed]
110. Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem Biophys Res Commun. 2008;377:1195–8. [PubMed]
111. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–61. [PMC free article] [PubMed]
112. Kamimura N, Nishimaki K, Ohsawa I, Ohta S. Molecular Hydrogen Improves Obesity and Diabetes by Inducing Hepatic FGF21 and Stimulating Energy Metabolism in db/db Mice. Obesity (Silver Spring) 2011 in press. [PubMed]
113. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334:115–24. [PubMed]
114. Kitamura A, Kobayashi S, Matsushita T, Fujinawa H, Murase K. Experimental verification of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced CT. Br. J. Radiol. 2010;83:509–14. [PMC free article] [PubMed]
115. Itoh T, Fujita Y, Ito M, et al. Molecular hydrogen suppresses FcepsilonRI-mediated signal transduction and prevents degranulation of mast cells. Biochem Biophys Res Commun. 2009;389:651–6. [PubMed]
116. Cardinal JS, Zhan J, Wang Y, et al. Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int. 2010;77:101–9. [PubMed]
117. Sato Y, Kajiyama S, Amano A, et al. Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2008;375:346–50. [PubMed]
118. Lin Y, Kashio A, Sakamoto T, Suzukawa K, Kakigi A, Yamasoba T. Hydrogen in drinking water attenuates noise-induced hearing loss in guinea pigs. Neurosci Lett. 2011;487:12–6. [PubMed]
119. Gu Y, Huang CS, Inoue T, Yamashita T, Ishida T, Kang KM, Nakao A. Drinking Hydrogen Water Ameliorated Cognitive Impairment in Senescence-Accelerated Mice. Journal of Clinical Biochemistry and Nutrition. 2010;46:269–76. [PMC free article] [PubMed]
120. Qian LR, Cao F, Cui JG, et al. The Potential Cardioprotective Effects of Hydrogen in Irradiated Mice. J. Radiat. Res. (Tokyo) 2010;51:741–7. [PubMed]
121. Cai JM, Kang ZM, Liu K, et al. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009;1256:129–37. [PubMed]
122. Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Brain Res. 2010;1328:152–61. [PubMed]
123. Chen C, Chen Q, Mao Y, et al. Hydrogen-rich saline protects against spinal cord injury in rats. Neurochem Res. 2010;35:1111–8. [PubMed]
124. Liu Q, Shen WF, Sun HY, et al. Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice. Liver Int. 2010;30:958–68. [PubMed]
125. Mao YF, Zheng XF, Cai JM, et al. Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochem Biophys Res Commun. 2009;381:602–5. [PubMed]
126. Qian L, Cao F, Cui J, et al. The potential cardioprotective effects of hydrogen in irradiated mice. J Radiat Res (Tokyo) 2010;51:741–7. [PubMed]
127. Shingu C, Koga H, Hagiwara S, Matsumoto S, Goto K, Yokoi I, Noguchi T. Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury. J Anesth. 2010;24:569–74. [PubMed]
128. Sun Q, Cai J, Liu S, Liu Y, Xu W, Tao H, Sun X. Hydrogen-rich saline provides protection against hyperoxic lung injury. J Surg Res. 2011;165:e43–9. [PubMed]
129. Zheng J, Liu K, Kang Z, et al. Saturated hydrogen saline protects the lung against oxygen toxicity. Undersea Hyperb Med. 2010;37:185–92. [PubMed]
130. Zheng X, Mao Y, Cai J, et al. Hydrogen-rich saline protects against intestinal ischemia/reperfusion injury in rats. Free Radic Res. 2009;43:478–84. [PubMed]
131. Oharazawa H, Igarashi T, Yokota T, et al. Protection of the retina by rapid diffusion of hydrogen: administration of hydrogen-loaded eye drops in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2010;51:487–92. [PubMed]
132. Kubota M, Shimmura S, Kubota S, et al. Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sci. 2011;52:427–33. [PubMed]
133. Nakabayashi M. Review of the ischemia hypothesis for ocular hypertension other than congenital glaucoma and closed-angle glaucoma. Ophthalmologica. 2004;218:344–9. [PubMed]
134. Thauer RK, Jungermann K, Decker K. Energy conservation in chemotrophic anaerobic bacteria. Bacteriol Rev. 1977;41:100–80. [PMC free article] [PubMed]
135. Levitt MD. Production and excretion of hydrogen gas in man. N. Engl. J. Med. 1969;281:122–7. [PubMed]
136. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290:486–94. [PubMed]
137. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur. Heart J. 2004;25:10–6. [PubMed]
138. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53. [PubMed]
139. Suzuki Y, Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K. Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? FEBS Lett. 2009;583:2157–9. [PubMed]
140. Kajiya M, Sato K, Silva MJ, et al. Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis. Biochem. Biophys. Res. Commun. 2009;386:316–21. [PubMed]
141. Kajiya M, Silva MJ, Sato K, Ouhara K, Kawai T. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate. Biochem Biophys Res Commun. 2009;386:11–5. [PubMed]
142. Shimouchi A, Nose K, Takaoka M, Hayashi H, Kondo T. Effect of dietary turmeric on breath hydrogen. Dig Dis Sci. 2009;54:1725–9. [PubMed]
143. Chen X, Zuo Q, Hai Y, Sun XJ. Lactulose: an indirect antioxidant ameliorating inflammatory bowel disease by increasing hydrogen production. Med Hypotheses. 2011;76:325–7. [PubMed]
144. Kajiyama S, Hasegawa G, Asano M, et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res. 2008;28:137–43. [PubMed]
145. Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr. 2010;46:140–9. [PMC free article] [PubMed]
146. Nakayama M, Nakano H, Hamada H, Itami N, Nakazawa R, Ito S. A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial. Nephrol. Dial. Transplant. 2010;25:3026–33. [PubMed]
147. Xie K, Yu Y, Pei Y, Hou L, Chen S, Xiong L, Wang G. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock. 2010;34:90–7. [PubMed]
148. Chen H, Sun YP, Li Y, et al. Hydrogen-rich saline ameliorates the severity of l-arginine-induced acute pancreatitis in rats. Biochem Biophys Res Commun. 2010;393:308–13. [PubMed]
149. Sun Q, Kang Z, Cai J, et al. Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats. Exp Biol Med (Maywood) 2009;234:1212–9. [PubMed]
150. Jazwa A, Cuadrado A. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets. 2010;11:1517–31. [PubMed]
151. Park DJ, Agarwal A, George JF. Heme oxygenase-1 expression in murine dendritic cell subpopulations: effect on CD8+ dendritic cell differentiation in vivo. Am J Pathol. 2010;176:2831–9. [PMC free article] [PubMed]
152. Ohta S, Nakao A, Ohno K. The 2011 Medical Molecular Hydrogen Symposium: An Inaugural Symposium of the Journal Medical Gas Research. Medical Gas Research. 2011;1:10. [PMC free article] [PubMed]